1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NKPD1 CTRPv2 pan-cancer AAC 0.092 0.009
mRNA SERPINA9 CTRPv2 pan-cancer AAC -0.091 0.009
mRNA ALS2CL CTRPv2 pan-cancer AAC 0.1 0.009
mRNA ZFP82 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA PAPD7 CTRPv2 pan-cancer AAC -0.094 0.009
mRNA GATA6 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA CCNI CTRPv2 pan-cancer AAC -0.098 0.009
mRNA INSR CTRPv2 pan-cancer AAC 0.099 0.009
mRNA ZNF117 CTRPv2 pan-cancer AAC 0.09 0.009
mRNA CEP164 CTRPv2 pan-cancer AAC -0.093 0.009
Download CSV